Nutra Pharma Corp.
NPHC
$0.00
$0.00100.00%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 23.73% | 21.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 23.73% | 21.73% | |||
| Cost of Revenue | 15.48% | -10.40% | |||
| Gross Profit | 29.01% | 55.68% | |||
| SG&A Expenses | -6.89% | -17.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.48% | -16.30% | |||
| Operating Income | 15.81% | 25.67% | |||
| Income Before Tax | 28.98% | 14.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.98% | 14.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.98% | 14.01% | |||
| EBIT | 15.81% | 25.67% | |||
| EBITDA | 15.95% | 25.84% | |||
| EPS Basic | -- | 100.00% | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | 100.00% | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 0.00% | 0.18% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.18% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||